Sishir K Kamalapuram,1 Rupinder K Kanwar,1 Kislay Roy,1 Rajneesh Chaudhary,1 Rakesh Sehgal,2 Jagat R Kanwar1 1Nanomedicine Laboratory of Immunology and Molecular Biomedical Research, School of Medicine, Centre for Molecular and Medical Research, Faculty of Health, Deakin University, Geelong, VIC, Australia; 2Department of Medical Parasitology, Postgraduate Institute of Medical Education and Research, Chandigarh, India Abstract: The present study successfully developed orally deliverable multimodular zinc (Zn) iron oxide (Fe3O4)-saturated bovine lactoferrin (bLf)-loaded polymeric nanocapsules (NCs), and evaluated their theranostic potential (antitumor efficacy, magnetophotothermal efficacy and imaging capability) in an in vivo human xenograf...
Breast cancer remains one of the most prevalent and lethal malignancies in women. The inability to d...
Background Iron nanoparticles (INPs) are usually prepared from inorganic sources, but we have prepar...
Single drug therapies for cancer are often suboptimal and may not provide long term clinical benefit...
The present study successfully developed orally deliverable multimodular zinc (Zn) iron oxide (Fe3O4...
AIM: To unravel the multimodal nanotheranostic ability of Fe3O4-saturated bovine lactoferrin nanocap...
Efficient early detection of cancer and its simultaneous therapy can improve the survival of cancer ...
Ganesh Mahidhara, Rupinder K Kanwar, Kislay Roy, Jagat R Kanwar Nanomedicine-Laboratory of Immunolo...
This is the first ever attempt to combine anti-cancer therapeutic effects of emerging anticancer bio...
noA major drawback with current cancer therapy is the prevalence of unrequired doselimiting toxicity...
A major drawback with current cancer therapy is the prevalence of unrequired dose-limiting toxicity ...
According to the World Health Organization, breast cancer is the most common oncological disease wor...
International audienceBACKGROUND: Iron nanoparticles (INPs) are usually prepared from inorganic sour...
International audienceBACKGROUND: Iron nanoparticles (INPs) are usually prepared from inorganic sour...
According to the World Health Organization, breast cancer is the most common oncological disease wor...
We determined the anticancer efficacy and internalization mechanism of our polymeric-ceramic nanopar...
Breast cancer remains one of the most prevalent and lethal malignancies in women. The inability to d...
Background Iron nanoparticles (INPs) are usually prepared from inorganic sources, but we have prepar...
Single drug therapies for cancer are often suboptimal and may not provide long term clinical benefit...
The present study successfully developed orally deliverable multimodular zinc (Zn) iron oxide (Fe3O4...
AIM: To unravel the multimodal nanotheranostic ability of Fe3O4-saturated bovine lactoferrin nanocap...
Efficient early detection of cancer and its simultaneous therapy can improve the survival of cancer ...
Ganesh Mahidhara, Rupinder K Kanwar, Kislay Roy, Jagat R Kanwar Nanomedicine-Laboratory of Immunolo...
This is the first ever attempt to combine anti-cancer therapeutic effects of emerging anticancer bio...
noA major drawback with current cancer therapy is the prevalence of unrequired doselimiting toxicity...
A major drawback with current cancer therapy is the prevalence of unrequired dose-limiting toxicity ...
According to the World Health Organization, breast cancer is the most common oncological disease wor...
International audienceBACKGROUND: Iron nanoparticles (INPs) are usually prepared from inorganic sour...
International audienceBACKGROUND: Iron nanoparticles (INPs) are usually prepared from inorganic sour...
According to the World Health Organization, breast cancer is the most common oncological disease wor...
We determined the anticancer efficacy and internalization mechanism of our polymeric-ceramic nanopar...
Breast cancer remains one of the most prevalent and lethal malignancies in women. The inability to d...
Background Iron nanoparticles (INPs) are usually prepared from inorganic sources, but we have prepar...
Single drug therapies for cancer are often suboptimal and may not provide long term clinical benefit...